Vascular infection study for patients 18 and older
Part of Heart & circulation, Infections clinical trials.
This trial is studying patients with infections in blood vessels, whether natural or from a graft, to better understand and treat them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have a blood vessel infection, either in a natural vessel or in a graft or stent
- You can give oral permission to join
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the body responds to infections in artificial blood vessels (vascular grafts or endografts). It may help understand why some people get infections and how to better treat them.
This study looks back at patient records to learn more about fungal infections in vascular grafts (artificial blood vessel replacements). It aims to better understand how to diagnose and treat these rare but serious infections.
This trial looks at adults with a specific type of blood vessel infection caused by the bacteria Coxiella burnetii. Researchers will review past cases to better understand these infections and how to treat them.
This trial studies how to care for infections that involve the aorta or other large blood vessels. If you have signs and test results that fit this diagnosis, you may be invited to help researchers better understand the condition and treatments.
This study tracks people 18 and older who were treated with a JOTEC vascular graft. It checks how well the graft and follow-up care work over time for certain blood vessel problems.
This trial aims to learn more about blood clots, inflammation, and blood vessel problems. It may help researchers better understand these conditions and how they affect people.
Hear when a new Aortitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.